455 related articles for article (PubMed ID: 17668070)
41. Artesunate suppresses tumor growth and induces apoptosis through the modulation of multiple oncogenic cascades in a chronic myeloid leukemia xenograft mouse model.
Kim C; Lee JH; Kim SH; Sethi G; Ahn KS
Oncotarget; 2015 Feb; 6(6):4020-35. PubMed ID: 25738364
[TBL] [Abstract][Full Text] [Related]
42. H1, a derivative of Tetrandrine, exerts anti-MDR activity by initiating intrinsic apoptosis pathway and inhibiting the activation of Erk1/2 and Akt1/2.
Wei N; Liu GT; Chen XG; Liu Q; Wang FP; Sun H
Biochem Pharmacol; 2011 Dec; 82(11):1593-603. PubMed ID: 21864508
[TBL] [Abstract][Full Text] [Related]
43. Modulation of multidrug resistance P-glycoprotein activity by antiemetic compounds in human doxorubicin-resistant sarcoma cells (MES-SA/Dx-5): implications on cancer therapy.
Angelini A; Conti P; Ciofani G; Cuccurullo F; Di Ilio C
J Biol Regul Homeost Agents; 2013; 27(4):1029-37. PubMed ID: 24382184
[TBL] [Abstract][Full Text] [Related]
44. Glaucocalyxin A induces apoptosis in human leukemia HL-60 cells through mitochondria-mediated death pathway.
Gao LW; Zhang J; Yang WH; Wang B; Wang JW
Toxicol In Vitro; 2011 Feb; 25(1):51-63. PubMed ID: 20851175
[TBL] [Abstract][Full Text] [Related]
45. Apoptosis induced by anthracycline antibiotics in P388 parent and multidrug-resistant cells.
Ling YH; Priebe W; Perez-Soler R
Cancer Res; 1993 Apr; 53(8):1845-52. PubMed ID: 8467504
[TBL] [Abstract][Full Text] [Related]
46. Morphine inhibits doxorubicin-induced reactive oxygen species generation and nuclear factor kappaB transcriptional activation in neuroblastoma SH-SY5Y cells.
Lin X; Li Q; Wang YJ; Ju YW; Chi ZQ; Wang MW; Liu JG
Biochem J; 2007 Sep; 406(2):215-21. PubMed ID: 17542780
[TBL] [Abstract][Full Text] [Related]
47. Abrogation of MAPK and Akt signaling by AEE788 synergistically potentiates histone deacetylase inhibitor-induced apoptosis through reactive oxygen species generation.
Yu C; Friday BB; Lai JP; McCollum A; Atadja P; Roberts LR; Adjei AA
Clin Cancer Res; 2007 Feb; 13(4):1140-8. PubMed ID: 17317822
[TBL] [Abstract][Full Text] [Related]
48. Tetrathiomolybdate induces doxorubicin sensitivity in resistant tumor cell lines.
Kim KK; Kawar NM; Singh RK; Lange TS; Brard L; Moore RG
Gynecol Oncol; 2011 Jul; 122(1):183-9. PubMed ID: 21529906
[TBL] [Abstract][Full Text] [Related]
49. Balance of NF-kappaB and p38 MAPK is a determinant of radiosensitivity of the AML-2 and its doxorubicin-resistant cell lines.
Choi CH; Xu H; Bark H; Lee TB; Yun J; Kang SI; Oh YK
Leuk Res; 2007 Sep; 31(9):1267-76. PubMed ID: 17218010
[TBL] [Abstract][Full Text] [Related]
50. Repurposing the anti-malarial drug artesunate as a novel therapeutic agent for metastatic renal cell carcinoma due to its attenuation of tumor growth, metastasis, and angiogenesis.
Jeong DE; Song HJ; Lim S; Lee SJ; Lim JE; Nam DH; Joo KM; Jeong BC; Jeon SS; Choi HY; Lee HW
Oncotarget; 2015 Oct; 6(32):33046-64. PubMed ID: 26426994
[TBL] [Abstract][Full Text] [Related]
51. Cathepsin E enhances anticancer activity of doxorubicin on human prostate cancer cells showing resistance to TRAIL-mediated apoptosis.
Yasukochi A; Kawakubo T; Nakamura S; Yamamoto K
Biol Chem; 2010 Aug; 391(8):947-58. PubMed ID: 20482316
[TBL] [Abstract][Full Text] [Related]
52. Ornithine decarboxylase attenuates leukemic chemotherapy drugs-induced cell apoptosis and arrest in human promyelocytic HL-60 cells.
Hsu PC; Hung HC; Liao YF; Liu CC; Tsay GJ; Liu GY
Leuk Res; 2008 Oct; 32(10):1530-40. PubMed ID: 18339422
[TBL] [Abstract][Full Text] [Related]
53. Surfactin induces apoptosis in human breast cancer MCF-7 cells through a ROS/JNK-mediated mitochondrial/caspase pathway.
Cao XH; Wang AH; Wang CL; Mao DZ; Lu MF; Cui YQ; Jiao RZ
Chem Biol Interact; 2010 Feb; 183(3):357-62. PubMed ID: 19954742
[TBL] [Abstract][Full Text] [Related]
54. Efficient induction of apoptosis by doxorubicin coupled to cell-penetrating peptides compared to unconjugated doxorubicin in the human breast cancer cell line MDA-MB 231.
Aroui S; Brahim S; De Waard M; Bréard J; Kenani A
Cancer Lett; 2009 Nov; 285(1):28-38. PubMed ID: 19523755
[TBL] [Abstract][Full Text] [Related]
55. ROS and RNS induced apoptosis through p53 and iNOS mediated pathway by a dibasic hydroxamic acid molecule in leukemia cells.
Banerjee K; Ganguly A; Chakraborty P; Sarkar A; Singh S; Chatterjee M; Bhattacharya S; Choudhuri SK
Eur J Pharm Sci; 2014 Feb; 52():146-64. PubMed ID: 24269727
[TBL] [Abstract][Full Text] [Related]
56. Reversal of P-glycoprotein-mediated multidrug resistance by guggulsterone in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells.
Xu HB; Li L; Liu GQ
Pharmazie; 2009 Oct; 64(10):660-5. PubMed ID: 19947169
[TBL] [Abstract][Full Text] [Related]
57. Apoptosis repressor with caspase recruitment domain contributes to chemotherapy resistance by abolishing mitochondrial fission mediated by dynamin-related protein-1.
Wang JX; Li Q; Li PF
Cancer Res; 2009 Jan; 69(2):492-500. PubMed ID: 19147562
[TBL] [Abstract][Full Text] [Related]
58. Mechanisms of the pH- and Oxygen-Dependent Oxidation Activities of Artesunate.
Tsuda K; Miyamoto L; Hamano S; Morimoto Y; Kangawa Y; Fukue C; Kagawa Y; Horinouchi Y; Xu W; Ikeda Y; Tamaki T; Tsuchiya K
Biol Pharm Bull; 2018; 41(4):555-563. PubMed ID: 29607928
[TBL] [Abstract][Full Text] [Related]
59. Synergistic induction of oxidative injury and apoptosis in human multiple myeloma cells by the proteasome inhibitor bortezomib and histone deacetylase inhibitors.
Pei XY; Dai Y; Grant S
Clin Cancer Res; 2004 Jun; 10(11):3839-52. PubMed ID: 15173093
[TBL] [Abstract][Full Text] [Related]
60. Modulation of multidrug resistance p-glycoprotein activity by flavonoids and honokiol in human doxorubicin- resistant sarcoma cells (MES-SA/DX-5): implications for natural sedatives as chemosensitizing agents in cancer therapy.
Angelini A; Di Ilio C; Castellani ML; Conti P; Cuccurullo F
J Biol Regul Homeost Agents; 2010; 24(2):197-205. PubMed ID: 20487633
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
